TradingKey – Shares of Rocket Lab (RKLB) were down 6.64%, to close at $55.25, on Thursday, October 15, after slipping as much as 16% intraday, following Rocket Lab’s disclosure that the first Neutron launch has been moved to 2027. This extended a six-session losing streak, now about 21%.
My thesis is that the core business is healthy and the growth story now relies on 2 key things the market cannot price with certainty: Execution of Neutron and the financing of the $8bn Iridium deal. The Q3 report in November is the next catalyst.
Why the Neutron Delay Matters
Neutron is Rocket Lab’s medium-lift, reusable rocket, to compete with SpaceX’s Falcon 9, and carry a lot bigger payloads than Electron. In its October 14 report, Rocket Lab…
